I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 6.9 SEK 5.34% Market Closed
Market Cap: 365.1m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Initiator Pharma A/S
Operating Income Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Operating Income
-kr27m
CAGR 3-Years
-37%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Operating Income
kr6B
CAGR 3-Years
25%
CAGR 5-Years
42%
CAGR 10-Years
48%
Zealand Pharma A/S
CSE:ZEAL
Operating Income
-kr1.1B
CAGR 3-Years
-2%
CAGR 5-Years
-16%
CAGR 10-Years
-36%
Ascendis Pharma A/S
NASDAQ:ASND
Operating Income
-€353.4m
CAGR 3-Years
5%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Operating Income
kr723.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
88%
Bioporto A/S
CSE:BIOPOR
Operating Income
-kr57.9m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
-11%

See Also

What is Initiator Pharma A/S's Operating Income?
Operating Income
-27m DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Operating Income amounts to -27m DKK.

What is Initiator Pharma A/S's Operating Income growth rate?
Operating Income CAGR 5Y
-16%

Over the last year, the Operating Income growth was 35%. The average annual Operating Income growth rates for Initiator Pharma A/S have been -37% over the past three years , -16% over the past five years .

Back to Top